

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | purine nucleobase biosynthetic process (GO:0009113) | 5.84525319 |
| 2 | proteasome assembly (GO:0043248) | 5.58132771 |
| 3 | nucleobase biosynthetic process (GO:0046112) | 5.29268947 |
| 4 | ribosome assembly (GO:0042255) | 5.05915933 |
| 5 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 4.78197473 |
| 6 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 4.73431260 |
| 7 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 4.71157141 |
| 8 | folic acid metabolic process (GO:0046655) | 4.62050403 |
| 9 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 4.61885534 |
| 10 | amino acid salvage (GO:0043102) | 4.60388009 |
| 11 | L-methionine salvage (GO:0071267) | 4.60388009 |
| 12 | L-methionine biosynthetic process (GO:0071265) | 4.60388009 |
| 13 | mannose metabolic process (GO:0006013) | 4.56128072 |
| 14 | termination of RNA polymerase III transcription (GO:0006386) | 4.55278764 |
| 15 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 4.55278764 |
| 16 | folic acid transport (GO:0015884) | 4.46628471 |
| 17 | DNA deamination (GO:0045006) | 4.35345463 |
| 18 | formation of translation preinitiation complex (GO:0001731) | 4.32699226 |
| 19 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 4.22988756 |
| 20 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 4.22611820 |
| 21 | negative regulation of ligase activity (GO:0051352) | 4.22611820 |
| 22 | ribosome biogenesis (GO:0042254) | 4.22277429 |
| 23 | maturation of SSU-rRNA (GO:0030490) | 4.19577346 |
| 24 | regulation of ARF GTPase activity (GO:0032312) | 4.18987764 |
| 25 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 4.08914082 |
| 26 | regulation of cellular amino acid metabolic process (GO:0006521) | 4.03097654 |
| 27 | 7-methylguanosine mRNA capping (GO:0006370) | 4.02372164 |
| 28 | mitotic metaphase plate congression (GO:0007080) | 4.01842857 |
| 29 | rRNA modification (GO:0000154) | 4.01238216 |
| 30 | positive regulation of ligase activity (GO:0051351) | 4.00955505 |
| 31 | DNA replication checkpoint (GO:0000076) | 4.00874746 |
| 32 | spliceosomal tri-snRNP complex assembly (GO:0000244) | 3.96842367 |
| 33 | cullin deneddylation (GO:0010388) | 3.96562943 |
| 34 | histone H4-K12 acetylation (GO:0043983) | 3.93990619 |
| 35 | 7-methylguanosine RNA capping (GO:0009452) | 3.85577963 |
| 36 | RNA capping (GO:0036260) | 3.85577963 |
| 37 | spliceosomal snRNP assembly (GO:0000387) | 3.85392701 |
| 38 | protein retention in ER lumen (GO:0006621) | 3.83199780 |
| 39 | methionine biosynthetic process (GO:0009086) | 3.82691141 |
| 40 | regulation of translation in response to stress (GO:0043555) | 3.77603573 |
| 41 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 3.72808343 |
| 42 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 3.72808343 |
| 43 | protein deneddylation (GO:0000338) | 3.71931684 |
| 44 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 3.71154102 |
| 45 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 3.71154102 |
| 46 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 3.71154102 |
| 47 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 3.69599100 |
| 48 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 3.65952901 |
| 49 | Golgi transport vesicle coating (GO:0048200) | 3.65274844 |
| 50 | COPI coating of Golgi vesicle (GO:0048205) | 3.65274844 |
| 51 | regulation of ubiquitin-protein transferase activity (GO:0051438) | 3.64531062 |
| 52 | transcription elongation from RNA polymerase I promoter (GO:0006362) | 3.63732058 |
| 53 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 3.61645564 |
| 54 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 3.61645564 |
| 55 | termination of RNA polymerase I transcription (GO:0006363) | 3.58060069 |
| 56 | methionine metabolic process (GO:0006555) | 3.56797831 |
| 57 | regulation of mitochondrial translation (GO:0070129) | 3.56495019 |
| 58 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.56447981 |
| 59 | ribonucleoprotein complex biogenesis (GO:0022613) | 3.55893548 |
| 60 | transcription from RNA polymerase I promoter (GO:0006360) | 3.54185785 |
| 61 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.51725772 |
| 62 | cell-cell junction maintenance (GO:0045217) | 3.50735071 |
| 63 | GMP metabolic process (GO:0046037) | 3.49769448 |
| 64 | activation of MAPKKK activity (GO:0000185) | 3.48589731 |
| 65 | regulation of ligase activity (GO:0051340) | 3.48581023 |
| 66 | negative regulation of cell size (GO:0045792) | 3.46612387 |
| 67 | rRNA processing (GO:0006364) | 3.43985955 |
| 68 | regulation of spindle organization (GO:0090224) | 3.43540925 |
| 69 | plasma lipoprotein particle assembly (GO:0034377) | 3.42415928 |
| 70 | proline biosynthetic process (GO:0006561) | 3.41420291 |
| 71 | regulation of translational termination (GO:0006449) | 3.39702408 |
| 72 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 3.39072712 |
| 73 | ribosomal large subunit biogenesis (GO:0042273) | 3.38134783 |
| 74 | lung-associated mesenchyme development (GO:0060484) | 3.36764828 |
| 75 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 3.36556829 |
| 76 | DNA strand elongation (GO:0022616) | 3.36136344 |
| 77 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.35630219 |
| 78 | blastocyst development (GO:0001824) | 3.34990770 |
| 79 | peptidyl-arginine omega-N-methylation (GO:0035247) | 3.32803832 |
| 80 | protein-lipid complex assembly (GO:0065005) | 3.32170991 |
| 81 | glucose 6-phosphate metabolic process (GO:0051156) | 3.31032399 |
| 82 | rRNA metabolic process (GO:0016072) | 3.30861113 |
| 83 | viral mRNA export from host cell nucleus (GO:0046784) | 3.30418757 |
| 84 | NIK/NF-kappaB signaling (GO:0038061) | 3.27909298 |
| 85 | mitotic spindle assembly checkpoint (GO:0007094) | 3.25773991 |
| 86 | cell junction maintenance (GO:0034331) | 3.24692588 |
| 87 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.24586087 |
| 88 | transcription elongation from RNA polymerase II promoter (GO:0006368) | 3.23934780 |
| 89 | histone H4 deacetylation (GO:0070933) | 3.23085897 |
| 90 | sulfur amino acid biosynthetic process (GO:0000097) | 3.22441981 |
| 91 | modulation by virus of host process (GO:0019054) | 3.22362285 |
| 92 | DNA-templated transcription, elongation (GO:0006354) | 3.21826585 |
| 93 | semaphorin-plexin signaling pathway (GO:0071526) | 3.19353776 |
| 94 | negative regulation of mitotic metaphase/anaphase transition (GO:0045841) | 3.18261924 |
| 95 | negative regulation of sister chromatid segregation (GO:0033046) | 3.18261924 |
| 96 | negative regulation of mitotic sister chromatid separation (GO:2000816) | 3.18261924 |
| 97 | negative regulation of mitotic sister chromatid segregation (GO:0033048) | 3.18261924 |
| 98 | aspartate family amino acid biosynthetic process (GO:0009067) | 3.17729876 |
| 99 | pseudouridine synthesis (GO:0001522) | 3.17660572 |
| 100 | apoptotic process involved in morphogenesis (GO:0060561) | 3.17310882 |
| 101 | G1/S transition of mitotic cell cycle (GO:0000082) | 3.17179837 |
| 102 | cell cycle G1/S phase transition (GO:0044843) | 3.17179837 |
| 103 | intracellular estrogen receptor signaling pathway (GO:0030520) | 3.16692818 |
| 104 | spindle assembly checkpoint (GO:0071173) | 3.16622520 |
| 105 | negative regulation of chromosome segregation (GO:0051985) | 3.16341283 |
| 106 | regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083) | 3.15436482 |
| 107 | mitotic spindle checkpoint (GO:0071174) | 3.15201662 |
| 108 | regulation of G0 to G1 transition (GO:0070316) | 3.14989811 |
| 109 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 3.14952402 |
| 110 | spliceosomal complex assembly (GO:0000245) | 3.14638242 |
| 111 | transcription initiation from RNA polymerase I promoter (GO:0006361) | 3.14627832 |
| 112 | spindle checkpoint (GO:0031577) | 3.13926508 |
| 113 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.13589208 |
| 114 | proline metabolic process (GO:0006560) | 3.13558199 |
| 115 | positive regulation of cell cycle arrest (GO:0071158) | 3.11822098 |
| 116 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.11394341 |
| 117 | GDP-mannose metabolic process (GO:0019673) | 3.11340243 |
| 118 | negative regulation of metaphase/anaphase transition of cell cycle (GO:1902100) | 3.07451148 |
| 119 | regulation of attachment of spindle microtubules to kinetochore (GO:0051988) | 3.07446703 |
| 120 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.07043345 |
| 121 | macrophage activation involved in immune response (GO:0002281) | 3.06795637 |
| 122 | transcription-coupled nucleotide-excision repair (GO:0006283) | 3.06334683 |
| 123 | cellular metabolic compound salvage (GO:0043094) | 3.04920383 |
| 124 | positive regulation of viral transcription (GO:0050434) | 3.04066602 |
| 125 | positive regulation of synapse maturation (GO:0090129) | 3.02341443 |
| 126 | regulation of cholesterol homeostasis (GO:2000188) | 3.02093658 |
| 127 | membrane tubulation (GO:0097320) | 3.02085150 |
| 128 | negative regulation of DNA-templated transcription, elongation (GO:0032785) | 3.01006978 |
| 129 | peptidyl-histidine modification (GO:0018202) | 3.00806842 |
| 130 | mitotic nuclear envelope disassembly (GO:0007077) | 2.99902560 |
| 131 | activation of Rac GTPase activity (GO:0032863) | 2.99045523 |
| 132 | negative regulation of translational initiation (GO:0045947) | 2.98254056 |
| 133 | negative regulation of protein ubiquitination (GO:0031397) | 2.98212967 |
| 134 | modulation by symbiont of host cellular process (GO:0044068) | 2.98124419 |
| 135 | protein localization to endosome (GO:0036010) | 2.97897349 |
| 136 | signal complex assembly (GO:0007172) | 2.97511157 |
| 137 | CDP-diacylglycerol metabolic process (GO:0046341) | 2.97429259 |
| 138 | regulation of hydrogen peroxide metabolic process (GO:0010310) | 2.96554340 |
| 139 | metaphase plate congression (GO:0051310) | 2.95713034 |
| 140 | protein-cofactor linkage (GO:0018065) | 2.94631019 |
| 141 | protein localization to kinetochore (GO:0034501) | 2.94123067 |
| 142 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 2.89060613 |
| 143 | regulation of ARF protein signal transduction (GO:0032012) | 2.88177560 |
| 144 | regulation of cholesterol biosynthetic process (GO:0045540) | 2.87718901 |
| 145 | very-low-density lipoprotein particle assembly (GO:0034379) | 2.87619179 |
| 146 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.87606406 |
| 147 | response to muramyl dipeptide (GO:0032495) | 2.87124802 |
| 148 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.86263289 |
| 149 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 2.85860979 |
| 150 | regulation of cholesterol metabolic process (GO:0090181) | 2.83185878 |
| 151 | diacylglycerol metabolic process (GO:0046339) | 2.78600924 |
| 152 | negative regulation of viral release from host cell (GO:1902187) | 2.78349908 |
| 153 | peptidyl-arginine N-methylation (GO:0035246) | 2.77549252 |
| 154 | peptidyl-arginine methylation (GO:0018216) | 2.77549252 |
| 155 | layer formation in cerebral cortex (GO:0021819) | 2.75258728 |
| 156 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.75222000 |
| 157 | protein maturation by protein folding (GO:0022417) | 2.73708597 |
| 158 | histone H3 deacetylation (GO:0070932) | 2.73368150 |
| 159 | positive regulation of nuclease activity (GO:0032075) | 2.72871463 |
| 160 | negative regulation of autophagy (GO:0010507) | 2.71938179 |
| 161 | regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315) | 2.67747224 |
| 162 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.67009817 |
| 163 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.67009817 |
| 164 | regulation of apoptotic cell clearance (GO:2000425) | 2.65712929 |
| 165 | positive regulation of histone deacetylation (GO:0031065) | 2.65429855 |
| 166 | fatty acid elongation (GO:0030497) | 2.60364270 |
| 167 | regulation of extracellular matrix disassembly (GO:0010715) | 2.59420617 |
| 168 | histone arginine methylation (GO:0034969) | 2.58846102 |
| 169 | low-density lipoprotein particle clearance (GO:0034383) | 2.58152227 |
| 170 | embryonic process involved in female pregnancy (GO:0060136) | 2.58144213 |
| 171 | protein insertion into membrane (GO:0051205) | 2.57994618 |
| 172 | barbed-end actin filament capping (GO:0051016) | 2.57096017 |
| 173 | retrograde transport, endosome to Golgi (GO:0042147) | 2.55564569 |
| 174 | maternal placenta development (GO:0001893) | 2.55180975 |
| 175 | snRNA metabolic process (GO:0016073) | 2.53175646 |
| 176 | regulation of extracellular matrix organization (GO:1903053) | 2.53113721 |
| 177 | regulation of cholesterol esterification (GO:0010872) | 2.51205217 |
| 178 | regulation of cholesterol storage (GO:0010885) | 2.50060254 |
| 179 | modulation by virus of host morphology or physiology (GO:0019048) | 2.49925925 |
| 180 | regulation of superoxide anion generation (GO:0032928) | 2.49191017 |
| 181 | thymic T cell selection (GO:0045061) | 2.48739760 |
| 182 | actin filament polymerization (GO:0030041) | 2.48304718 |
| 183 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.48007038 |
| 184 | establishment of mitochondrion localization, microtubule-mediated (GO:0034643) | 2.46729428 |
| 185 | mitochondrion transport along microtubule (GO:0047497) | 2.46729428 |
| 186 | planar cell polarity pathway involved in neural tube closure (GO:0090179) | 2.45664638 |
| 187 | UV protection (GO:0009650) | 2.45511218 |
| 188 | adherens junction assembly (GO:0034333) | 2.44970313 |
| 189 | positive regulation of protein dephosphorylation (GO:0035307) | 2.44966010 |
| 190 | regulation of synapse maturation (GO:0090128) | 2.44312556 |
| 191 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 2.43936741 |
| 192 | regulation of nuclease activity (GO:0032069) | 2.43754413 |
| 193 | establishment of mitochondrion localization (GO:0051654) | 2.43711007 |
| 194 | positive regulation of extracellular matrix organization (GO:1903055) | 2.43254885 |
| 195 | mitochondrial fragmentation involved in apoptotic process (GO:0043653) | 2.42143295 |
| 196 | positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:00360 | 2.41626887 |
| 197 | pentose-phosphate shunt (GO:0006098) | 2.41070252 |
| 198 | leukocyte aggregation (GO:0070486) | 2.40320426 |
| 199 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.39413383 |
| 200 | basement membrane organization (GO:0071711) | 2.37761072 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 4.30065108 |
| 2 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 3.98436631 |
| 3 | * JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 3.96409230 |
| 4 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.93832369 |
| 5 | * ETS1_20019798_ChIP-Seq_JURKAT_Human | 3.80348850 |
| 6 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.76112569 |
| 7 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 3.63294201 |
| 8 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 3.42742952 |
| 9 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 3.41310155 |
| 10 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 3.33481188 |
| 11 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 3.13458103 |
| 12 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 3.07378857 |
| 13 | LXR_22292898_ChIP-Seq_THP-1_Human | 3.00279941 |
| 14 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.93440534 |
| 15 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.91864637 |
| 16 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.89467992 |
| 17 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.76147530 |
| 18 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.75296133 |
| 19 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.68076530 |
| 20 | MYC_22102868_ChIP-Seq_BL_Human | 2.51136450 |
| 21 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 2.47852877 |
| 22 | XRN2_22483619_ChIP-Seq_HELA_Human | 2.44533547 |
| 23 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.39676853 |
| 24 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.39286906 |
| 25 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.37043937 |
| 26 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 2.34548540 |
| 27 | * VDR_23849224_ChIP-Seq_CD4+_Human | 2.34109023 |
| 28 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.32304835 |
| 29 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.31588309 |
| 30 | * HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.29811869 |
| 31 | GABP_19822575_ChIP-Seq_HepG2_Human | 2.26007622 |
| 32 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.24218585 |
| 33 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 2.22301854 |
| 34 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.21150480 |
| 35 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 2.20721782 |
| 36 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.17072346 |
| 37 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 2.15221953 |
| 38 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.14876512 |
| 39 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.12357072 |
| 40 | DCP1A_22483619_ChIP-Seq_HELA_Human | 2.11302999 |
| 41 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 2.09431807 |
| 42 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.08973533 |
| 43 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.08532647 |
| 44 | FOXP3_21729870_ChIP-Seq_TREG_Human | 2.00166237 |
| 45 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.98845826 |
| 46 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.98512731 |
| 47 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.95558434 |
| 48 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.91690083 |
| 49 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.88229344 |
| 50 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.87445501 |
| 51 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.86456431 |
| 52 | P68_20966046_ChIP-Seq_HELA_Human | 1.85122062 |
| 53 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.82902182 |
| 54 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.82279460 |
| 55 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.78661363 |
| 56 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.76715408 |
| 57 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.76400674 |
| 58 | * MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.76365324 |
| 59 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.75463404 |
| 60 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.71254880 |
| 61 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.70871330 |
| 62 | KDM2B_26808549_Chip-Seq_K562_Human | 1.69648181 |
| 63 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.68543042 |
| 64 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.68020183 |
| 65 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.67155800 |
| 66 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.65968344 |
| 67 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.65063804 |
| 68 | * CIITA_25753668_ChIP-Seq_RAJI_Human | 1.64920224 |
| 69 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.64192010 |
| 70 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.63921156 |
| 71 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.60163206 |
| 72 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.59690751 |
| 73 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.57378376 |
| 74 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.54906646 |
| 75 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.53760290 |
| 76 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.52517304 |
| 77 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.52163820 |
| 78 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.49854899 |
| 79 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.48614081 |
| 80 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.46770527 |
| 81 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.45634644 |
| 82 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.44782995 |
| 83 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.44668700 |
| 84 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.44117360 |
| 85 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.42064822 |
| 86 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.41250521 |
| 87 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.40675581 |
| 88 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.40626374 |
| 89 | MAF_26560356_Chip-Seq_TH2_Human | 1.39710405 |
| 90 | MAF_26560356_Chip-Seq_TH1_Human | 1.39206768 |
| 91 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.38857056 |
| 92 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.38575281 |
| 93 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.37609735 |
| 94 | UTX_26944678_Chip-Seq_JUKART_Human | 1.37441532 |
| 95 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.36545816 |
| 96 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.35644343 |
| 97 | * KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.33907019 |
| 98 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.31592329 |
| 99 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.30014405 |
| 100 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.29685205 |
| 101 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.29627262 |
| 102 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.29322931 |
| 103 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.28561283 |
| 104 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.27819875 |
| 105 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.27767285 |
| 106 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.25938487 |
| 107 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 1.23952632 |
| 108 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.22928269 |
| 109 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.22916726 |
| 110 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.22353272 |
| 111 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 1.21069504 |
| 112 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.21019199 |
| 113 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.20812357 |
| 114 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.20256797 |
| 115 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.18722542 |
| 116 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.18018991 |
| 117 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.16775870 |
| 118 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 1.16441151 |
| 119 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.16179268 |
| 120 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.15573818 |
| 121 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 1.15304065 |
| 122 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.14909088 |
| 123 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.14270109 |
| 124 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 1.14210285 |
| 125 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.13368172 |
| 126 | SETDB1_19884255_ChIP-Seq_MESCs_Mouse | 1.13098930 |
| 127 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.12642591 |
| 128 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.12605035 |
| 129 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.12250554 |
| 130 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.11354300 |
| 131 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.11015664 |
| 132 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.10365906 |
| 133 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.10215322 |
| 134 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.09786291 |
| 135 | * HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.09703100 |
| 136 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.09660174 |
| 137 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 1.08539597 |
| 138 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.08532982 |
| 139 | SA1_27219007_Chip-Seq_Bcells_Human | 1.08512583 |
| 140 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.08420337 |
| 141 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.07658660 |
| 142 | NANOG_21062744_ChIP-ChIP_HESCs_Human | 1.06795871 |
| 143 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.06731141 |
| 144 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.06138976 |
| 145 | ETS1_21867929_ChIP-Seq_TH2_Mouse | 1.05934975 |
| 146 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.05347841 |
| 147 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.05314385 |
| 148 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.05227600 |
| 149 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.04757870 |
| 150 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.04633455 |
| 151 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.04554973 |
| 152 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.04420166 |
| 153 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.04362845 |
| 154 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.04198711 |
| 155 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 1.03519250 |
| 156 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.02737455 |
| 157 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.00916754 |
| 158 | NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 1.00678648 |
| 159 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.00610164 |
| 160 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 1.00328429 |
| 161 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 0.99942172 |
| 162 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.99728650 |
| 163 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 0.98878119 |
| 164 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.98397603 |
| 165 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.97469282 |
| 166 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.97441805 |
| 167 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 0.97093394 |
| 168 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.95799297 |
| 169 | * FOXP1_21924763_ChIP-Seq_HESCs_Human | 0.94869382 |
| 170 | * CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.94776442 |
| 171 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 0.93703649 |
| 172 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.92406133 |
| 173 | * CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 0.91525895 |
| 174 | POU5F1_18692474_ChIP-Seq_MESCs_Mouse | 0.90647648 |
| 175 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 0.89511580 |
| 176 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 0.88393254 |
| 177 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.86326798 |
| 178 | * TCFCP2L1_18555785_ChIP-Seq_MESCs_Mouse | 0.85893481 |
| 179 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.85816548 |
| 180 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.85473000 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003693_abnormal_embryo_hatching | 6.79735128 |
| 2 | MP0003111_abnormal_nucleus_morphology | 5.40176901 |
| 3 | MP0004957_abnormal_blastocyst_morpholog | 4.57683084 |
| 4 | MP0003172_abnormal_lysosome_physiology | 3.80388434 |
| 5 | MP0010094_abnormal_chromosome_stability | 3.77491475 |
| 6 | MP0003077_abnormal_cell_cycle | 3.71146028 |
| 7 | MP0003718_maternal_effect | 3.71072900 |
| 8 | * MP0008260_abnormal_autophagy | 3.38988327 |
| 9 | MP0003436_decreased_susceptibility_to | 3.31452886 |
| 10 | MP0008932_abnormal_embryonic_tissue | 3.07788923 |
| 11 | MP0003786_premature_aging | 2.94674433 |
| 12 | MP0003705_abnormal_hypodermis_morpholog | 2.91378314 |
| 13 | MP0008058_abnormal_DNA_repair | 2.88563963 |
| 14 | MP0001849_ear_inflammation | 2.66580921 |
| 15 | MP0003315_abnormal_perineum_morphology | 2.58757385 |
| 16 | MP0002653_abnormal_ependyma_morphology | 2.47756777 |
| 17 | MP0004858_abnormal_nervous_system | 2.33399025 |
| 18 | MP0001542_abnormal_bone_strength | 2.30761990 |
| 19 | MP0001730_embryonic_growth_arrest | 2.28980576 |
| 20 | MP0009840_abnormal_foam_cell | 2.25043585 |
| 21 | MP0004859_abnormal_synaptic_plasticity | 2.18397573 |
| 22 | MP0003123_paternal_imprinting | 2.17599459 |
| 23 | MP0005076_abnormal_cell_differentiation | 2.15859064 |
| 24 | MP0009278_abnormal_bone_marrow | 2.14744258 |
| 25 | MP0003656_abnormal_erythrocyte_physiolo | 2.14427640 |
| 26 | MP0002089_abnormal_postnatal_growth/wei | 2.08859844 |
| 27 | MP0008007_abnormal_cellular_replicative | 2.08227116 |
| 28 | MP0003303_peritoneal_inflammation | 2.08056894 |
| 29 | MP0005409_darkened_coat_color | 2.04034980 |
| 30 | MP0000604_amyloidosis | 1.99256133 |
| 31 | MP0003806_abnormal_nucleotide_metabolis | 1.95297447 |
| 32 | MP0004147_increased_porphyrin_level | 1.95126161 |
| 33 | MP0004185_abnormal_adipocyte_glucose | 1.92622164 |
| 34 | MP0008057_abnormal_DNA_replication | 1.90521769 |
| 35 | MP0001986_abnormal_taste_sensitivity | 1.85369382 |
| 36 | MP0000678_abnormal_parathyroid_gland | 1.84225553 |
| 37 | MP0005360_urolithiasis | 1.78538395 |
| 38 | MP0000350_abnormal_cell_proliferation | 1.76086419 |
| 39 | MP0003183_abnormal_peptide_metabolism | 1.74270133 |
| 40 | MP0003221_abnormal_cardiomyocyte_apopto | 1.71034847 |
| 41 | MP0003122_maternal_imprinting | 1.70817542 |
| 42 | MP0005670_abnormal_white_adipose | 1.61937942 |
| 43 | MP0000358_abnormal_cell_content/ | 1.60341393 |
| 44 | MP0004381_abnormal_hair_follicle | 1.58973019 |
| 45 | MP0002249_abnormal_larynx_morphology | 1.58517098 |
| 46 | MP0003690_abnormal_glial_cell | 1.57964608 |
| 47 | MP0005380_embryogenesis_phenotype | 1.55609557 |
| 48 | MP0001672_abnormal_embryogenesis/_devel | 1.55609557 |
| 49 | MP0000858_altered_metastatic_potential | 1.55515521 |
| 50 | MP0002080_prenatal_lethality | 1.55327475 |
| 51 | MP0008877_abnormal_DNA_methylation | 1.54905386 |
| 52 | MP0005423_abnormal_somatic_nervous | 1.54832722 |
| 53 | MP0005025_abnormal_response_to | 1.51134154 |
| 54 | MP0003878_abnormal_ear_physiology | 1.50150419 |
| 55 | MP0005377_hearing/vestibular/ear_phenot | 1.50150419 |
| 56 | MP0000003_abnormal_adipose_tissue | 1.49786491 |
| 57 | MP0005666_abnormal_adipose_tissue | 1.48764325 |
| 58 | MP0000685_abnormal_immune_system | 1.48216475 |
| 59 | MP0005671_abnormal_response_to | 1.46036967 |
| 60 | MP0000490_abnormal_crypts_of | 1.44335204 |
| 61 | MP0003191_abnormal_cellular_cholesterol | 1.44122765 |
| 62 | MP0006035_abnormal_mitochondrial_morpho | 1.42534738 |
| 63 | MP0001727_abnormal_embryo_implantation | 1.39816729 |
| 64 | MP0002419_abnormal_innate_immunity | 1.39717252 |
| 65 | MP0000566_synostosis | 1.38146493 |
| 66 | MP0004947_skin_inflammation | 1.36517418 |
| 67 | MP0001697_abnormal_embryo_size | 1.35638836 |
| 68 | MP0000313_abnormal_cell_death | 1.34709034 |
| 69 | MP0009333_abnormal_splenocyte_physiolog | 1.33722506 |
| 70 | MP0002822_catalepsy | 1.33338017 |
| 71 | MP0005375_adipose_tissue_phenotype | 1.33026450 |
| 72 | MP0005395_other_phenotype | 1.31247858 |
| 73 | MP0006082_CNS_inflammation | 1.30697540 |
| 74 | MP0003984_embryonic_growth_retardation | 1.28147483 |
| 75 | MP0001756_abnormal_urination | 1.27560005 |
| 76 | MP0002088_abnormal_embryonic_growth/wei | 1.25039000 |
| 77 | MP0005257_abnormal_intraocular_pressure | 1.24686297 |
| 78 | MP0002085_abnormal_embryonic_tissue | 1.23880829 |
| 79 | MP0008995_early_reproductive_senescence | 1.23212422 |
| 80 | MP0005058_abnormal_lysosome_morphology | 1.21216232 |
| 81 | MP0010030_abnormal_orbit_morphology | 1.21084632 |
| 82 | MP0003879_abnormal_hair_cell | 1.20354732 |
| 83 | MP0003567_abnormal_fetal_cardiomyocyte | 1.19344983 |
| 84 | MP0002210_abnormal_sex_determination | 1.18653409 |
| 85 | MP0003453_abnormal_keratinocyte_physiol | 1.17956197 |
| 86 | MP0002160_abnormal_reproductive_system | 1.16784129 |
| 87 | MP0001915_intracranial_hemorrhage | 1.16761694 |
| 88 | MP0003329_amyloid_beta_deposits | 1.15047998 |
| 89 | MP0002139_abnormal_hepatobiliary_system | 1.14826102 |
| 90 | MP0003634_abnormal_glial_cell | 1.12873770 |
| 91 | MP0003300_gastrointestinal_ulcer | 1.12866844 |
| 92 | MP0005000_abnormal_immune_tolerance | 1.11549939 |
| 93 | MP0003119_abnormal_digestive_system | 1.11314981 |
| 94 | MP0008569_lethality_at_weaning | 1.08379058 |
| 95 | MP0001145_abnormal_male_reproductive | 1.07584505 |
| 96 | MP0002751_abnormal_autonomic_nervous | 1.05705266 |
| 97 | MP0001188_hyperpigmentation | 1.04617008 |
| 98 | MP0001348_abnormal_lacrimal_gland | 1.04479790 |
| 99 | MP0001661_extended_life_span | 1.04434075 |
| 100 | MP0003938_abnormal_ear_development | 1.03155477 |
| 101 | * MP0005384_cellular_phenotype | 1.02650739 |
| 102 | MP0006292_abnormal_olfactory_placode | 1.01860364 |
| 103 | MP0002933_joint_inflammation | 1.01747460 |
| 104 | MP0003186_abnormal_redox_activity | 1.01293886 |
| 105 | MP0002084_abnormal_developmental_patter | 1.00200389 |
| 106 | MP0001764_abnormal_homeostasis | 0.99522835 |
| 107 | MP0004019_abnormal_vitamin_homeostasis | 0.99304256 |
| 108 | MP0005389_reproductive_system_phenotype | 0.98784574 |
| 109 | MP0001533_abnormal_skeleton_physiology | 0.98545376 |
| 110 | MP0003566_abnormal_cell_adhesion | 0.97424270 |
| 111 | MP0003866_abnormal_defecation | 0.95927064 |
| 112 | MP0009384_cardiac_valve_regurgitation | 0.95744962 |
| 113 | MP0002102_abnormal_ear_morphology | 0.95542358 |
| 114 | MP0001800_abnormal_humoral_immune | 0.95104952 |
| 115 | MP0001819_abnormal_immune_cell | 0.94990011 |
| 116 | MP0002420_abnormal_adaptive_immunity | 0.94822467 |
| 117 | MP0001929_abnormal_gametogenesis | 0.94578179 |
| 118 | MP0005387_immune_system_phenotype | 0.94183452 |
| 119 | MP0001790_abnormal_immune_system | 0.94183452 |
| 120 | MP0002723_abnormal_immune_serum | 0.93465785 |
| 121 | * MP0005621_abnormal_cell_physiology | 0.93337532 |
| 122 | MP0000920_abnormal_myelination | 0.93098837 |
| 123 | MP0004270_analgesia | 0.92871047 |
| 124 | MP0000653_abnormal_sex_gland | 0.92080169 |
| 125 | MP0005623_abnormal_meninges_morphology | 0.91567227 |
| 126 | MP0002396_abnormal_hematopoietic_system | 0.90362966 |
| 127 | MP0002086_abnormal_extraembryonic_tissu | 0.89503597 |
| 128 | MP0006036_abnormal_mitochondrial_physio | 0.88892335 |
| 129 | MP0002998_abnormal_bone_remodeling | 0.84970785 |
| 130 | MP0003283_abnormal_digestive_organ | 0.84757457 |
| 131 | MP0002234_abnormal_pharynx_morphology | 0.84195169 |
| 132 | MP0005464_abnormal_platelet_physiology | 0.83562975 |
| 133 | MP0000428_abnormal_craniofacial_morphol | 0.83475788 |
| 134 | MP0002452_abnormal_antigen_presenting | 0.82994237 |
| 135 | MP0005166_decreased_susceptibility_to | 0.82294789 |
| 136 | MP0010155_abnormal_intestine_physiology | 0.81466705 |
| 137 | MP0000716_abnormal_immune_system | 0.79802725 |
| 138 | MP0003075_altered_response_to | 0.79127557 |
| 139 | MP0002019_abnormal_tumor_incidence | 0.78789035 |
| 140 | MP0004264_abnormal_extraembryonic_tissu | 0.77738448 |
| 141 | MP0003279_aneurysm | 0.77258969 |
| 142 | MP0008874_decreased_physiological_sensi | 0.76656522 |
| 143 | MP0000609_abnormal_liver_physiology | 0.75020609 |
| 144 | MP0005365_abnormal_bile_salt | 0.74853494 |
| 145 | MP0005332_abnormal_amino_acid | 0.73504320 |
| 146 | MP0002733_abnormal_thermal_nociception | 0.73259565 |
| 147 | MP0002429_abnormal_blood_cell | 0.72371710 |
| 148 | MP0010307_abnormal_tumor_latency | 0.71644446 |
| 149 | MP0002970_abnormal_white_adipose | 0.70361190 |
| 150 | MP0002398_abnormal_bone_marrow | 0.70292208 |
| 151 | MP0009672_abnormal_birth_weight | 0.70176985 |
| 152 | MP0004510_myositis | 0.70093846 |
| 153 | MP0005499_abnormal_olfactory_system | 0.69728589 |
| 154 | MP0005394_taste/olfaction_phenotype | 0.69728589 |
| 155 | MP0009785_altered_susceptibility_to | 0.69142855 |
| 156 | MP0002161_abnormal_fertility/fecundity | 0.68842974 |
| 157 | MP0002638_abnormal_pupillary_reflex | 0.68698109 |
| 158 | MP0003699_abnormal_female_reproductive | 0.66671923 |
| 159 | MP0000465_gastrointestinal_hemorrhage | 0.66670739 |
| 160 | MP0003763_abnormal_thymus_physiology | 0.65054243 |
| 161 | MP0002269_muscular_atrophy | 0.64543508 |
| 162 | MP0002722_abnormal_immune_system | 0.62539712 |
| 163 | MP0001529_abnormal_vocalization | 0.62448711 |
| 164 | MP0001853_heart_inflammation | 0.61720989 |
| 165 | MP0002405_respiratory_system_inflammati | 0.60780221 |
| 166 | MP0002132_abnormal_respiratory_system | 0.60189139 |
| 167 | MP0001119_abnormal_female_reproductive | 0.58618160 |
| 168 | MP0001545_abnormal_hematopoietic_system | 0.56620788 |
| 169 | MP0005397_hematopoietic_system_phenotyp | 0.56620788 |
| 170 | MP0003698_abnormal_male_reproductive | 0.55196167 |
| 171 | MP0004084_abnormal_cardiac_muscle | 0.54766404 |
| 172 | MP0009053_abnormal_anal_canal | 0.54170753 |
| 173 | MP0000750_abnormal_muscle_regeneration | 0.52921203 |
| 174 | MP0003121_genomic_imprinting | 0.52609671 |
| 175 | MP0005075_abnormal_melanosome_morpholog | 0.51260644 |
| 176 | MP0002169_no_abnormal_phenotype | 0.50634242 |
| 177 | MP0002111_abnormal_tail_morphology | 0.50311572 |
| 178 | MP0001919_abnormal_reproductive_system | 0.50085335 |
| 179 | MP0001293_anophthalmia | 0.50057313 |
| 180 | MP0005451_abnormal_body_composition | 0.49749955 |
| 181 | MP0002873_normal_phenotype | 0.49678493 |
| 182 | MP0009643_abnormal_urine_homeostasis | 0.49624143 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Cerebral hypomyelination (HP:0006808) | 5.58589319 |
| 2 | Breast hypoplasia (HP:0003187) | 5.34861868 |
| 3 | Rough bone trabeculation (HP:0100670) | 4.66574124 |
| 4 | Birth length less than 3rd percentile (HP:0003561) | 4.65331780 |
| 5 | Carpal bone hypoplasia (HP:0001498) | 4.62134799 |
| 6 | Deep venous thrombosis (HP:0002625) | 3.89649186 |
| 7 | Hyperglycinemia (HP:0002154) | 3.85367180 |
| 8 | Abnormality of the umbilical cord (HP:0010881) | 3.83181981 |
| 9 | Impulsivity (HP:0100710) | 3.77163163 |
| 10 | Secondary amenorrhea (HP:0000869) | 3.48990172 |
| 11 | Patellar aplasia (HP:0006443) | 3.39734384 |
| 12 | Aplasia/Hypoplasia of the patella (HP:0006498) | 3.38987247 |
| 13 | Aplasia/Hypoplasia involving the carpal bones (HP:0006502) | 3.22945817 |
| 14 | CNS hypomyelination (HP:0003429) | 3.21543265 |
| 15 | Delusions (HP:0000746) | 3.20521916 |
| 16 | Progressive muscle weakness (HP:0003323) | 3.20038090 |
| 17 | Distal upper limb amyotrophy (HP:0007149) | 3.16277285 |
| 18 | Upper limb amyotrophy (HP:0009129) | 3.16277285 |
| 19 | Ureteral duplication (HP:0000073) | 3.14903938 |
| 20 | Abnormal trabecular bone morphology (HP:0100671) | 3.12809671 |
| 21 | Hyperglycinuria (HP:0003108) | 3.10128664 |
| 22 | Premature ovarian failure (HP:0008209) | 3.10006855 |
| 23 | Abnormal gallbladder physiology (HP:0012438) | 3.09475445 |
| 24 | Cholecystitis (HP:0001082) | 3.09475445 |
| 25 | Degeneration of anterior horn cells (HP:0002398) | 3.08666653 |
| 26 | Abnormality of the anterior horn cell (HP:0006802) | 3.08666653 |
| 27 | Hemorrhage of the eye (HP:0011885) | 3.03098780 |
| 28 | Stridor (HP:0010307) | 2.96763324 |
| 29 | Deep palmar crease (HP:0006191) | 2.94052545 |
| 30 | Vertebral compression fractures (HP:0002953) | 2.84356412 |
| 31 | Oral leukoplakia (HP:0002745) | 2.82186812 |
| 32 | Supranuclear gaze palsy (HP:0000605) | 2.82034795 |
| 33 | Multiple enchondromatosis (HP:0005701) | 2.80801959 |
| 34 | Biconcave vertebral bodies (HP:0004586) | 2.77791254 |
| 35 | Abnormal number of erythroid precursors (HP:0012131) | 2.75450361 |
| 36 | Neuronal loss in central nervous system (HP:0002529) | 2.73155375 |
| 37 | Patent foramen ovale (HP:0001655) | 2.73066573 |
| 38 | Hand muscle atrophy (HP:0009130) | 2.70374879 |
| 39 | Aplasia/Hypoplasia involving the musculature (HP:0001460) | 2.69228260 |
| 40 | Hyperacusis (HP:0010780) | 2.65851617 |
| 41 | Abnormality of glycine metabolism (HP:0010895) | 2.65507202 |
| 42 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.65507202 |
| 43 | Personality changes (HP:0000751) | 2.63534646 |
| 44 | Systemic lupus erythematosus (HP:0002725) | 2.63353280 |
| 45 | Abnormal umbilical cord blood vessels (HP:0011403) | 2.63318001 |
| 46 | Single umbilical artery (HP:0001195) | 2.63318001 |
| 47 | Abnormality of the fetal cardiovascular system (HP:0010948) | 2.63318001 |
| 48 | Gout (HP:0001997) | 2.62843639 |
| 49 | Cerebral aneurysm (HP:0004944) | 2.60587142 |
| 50 | Long palpebral fissure (HP:0000637) | 2.60524553 |
| 51 | Obstructive sleep apnea (HP:0002870) | 2.59446956 |
| 52 | Absent radius (HP:0003974) | 2.56427621 |
| 53 | CNS demyelination (HP:0007305) | 2.55134066 |
| 54 | Death in infancy (HP:0001522) | 2.54321206 |
| 55 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.53674622 |
| 56 | Eczematoid dermatitis (HP:0000976) | 2.51753846 |
| 57 | Peripheral hypomyelination (HP:0007182) | 2.49974803 |
| 58 | Abnormalities of placenta or umbilical cord (HP:0001194) | 2.47042499 |
| 59 | Thin bony cortex (HP:0002753) | 2.46595372 |
| 60 | Achilles tendon contracture (HP:0001771) | 2.46475028 |
| 61 | Dysautonomia (HP:0002459) | 2.45062604 |
| 62 | Bundle branch block (HP:0011710) | 2.44724148 |
| 63 | Megaloblastic anemia (HP:0001889) | 2.44045239 |
| 64 | Ventricular fibrillation (HP:0001663) | 2.43794628 |
| 65 | Spinal muscular atrophy (HP:0007269) | 2.43554609 |
| 66 | Aplasia involving forearm bones (HP:0009822) | 2.41205342 |
| 67 | Absent forearm bone (HP:0003953) | 2.41205342 |
| 68 | Neurofibrillary tangles (HP:0002185) | 2.41202257 |
| 69 | Dysostosis multiplex (HP:0000943) | 2.39144791 |
| 70 | Xanthomatosis (HP:0000991) | 2.37865656 |
| 71 | Macrocytic anemia (HP:0001972) | 2.37788933 |
| 72 | Distal lower limb amyotrophy (HP:0008944) | 2.37252522 |
| 73 | Thoracic kyphosis (HP:0002942) | 2.35563825 |
| 74 | Postnatal microcephaly (HP:0005484) | 2.35560605 |
| 75 | Reticulocytosis (HP:0001923) | 2.35353314 |
| 76 | Broad face (HP:0000283) | 2.34743985 |
| 77 | Microvesicular hepatic steatosis (HP:0001414) | 2.34382113 |
| 78 | Microretrognathia (HP:0000308) | 2.32923575 |
| 79 | Abnormality of the Achilles tendon (HP:0005109) | 2.32075914 |
| 80 | Myopathic facies (HP:0002058) | 2.30370902 |
| 81 | Irregular epiphyses (HP:0010582) | 2.29320018 |
| 82 | Abnormality of the thoracic spine (HP:0100711) | 2.28752464 |
| 83 | Purpura (HP:0000979) | 2.28264280 |
| 84 | Entropion (HP:0000621) | 2.28195908 |
| 85 | Reticulocytopenia (HP:0001896) | 2.26053571 |
| 86 | Abnormality of serum amino acid levels (HP:0003112) | 2.25985194 |
| 87 | Ankle clonus (HP:0011448) | 2.25957489 |
| 88 | Difficulty climbing stairs (HP:0003551) | 2.25722700 |
| 89 | Emotional lability (HP:0000712) | 2.24531970 |
| 90 | Hypoplasia of the capital femoral epiphysis (HP:0003090) | 2.24301255 |
| 91 | Growth hormone excess (HP:0000845) | 2.23881525 |
| 92 | Loss of speech (HP:0002371) | 2.21075686 |
| 93 | Cellular immunodeficiency (HP:0005374) | 2.20798822 |
| 94 | Ragged-red muscle fibers (HP:0003200) | 2.19929363 |
| 95 | Flat capital femoral epiphysis (HP:0003370) | 2.18531276 |
| 96 | Abnormality of the labia minora (HP:0012880) | 2.18038005 |
| 97 | Sparse eyelashes (HP:0000653) | 2.18031140 |
| 98 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.17254091 |
| 99 | Cellulitis (HP:0100658) | 2.17239972 |
| 100 | Atrophy/Degeneration involving motor neurons (HP:0007373) | 2.16785645 |
| 101 | Neoplasm of the pancreas (HP:0002894) | 2.16321137 |
| 102 | J-shaped sella turcica (HP:0002680) | 2.16319592 |
| 103 | Horseshoe kidney (HP:0000085) | 2.16294658 |
| 104 | Lymphangioma (HP:0100764) | 2.16192485 |
| 105 | Prolonged neonatal jaundice (HP:0006579) | 2.16167917 |
| 106 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.15399637 |
| 107 | Abnormality of alanine metabolism (HP:0010916) | 2.15059682 |
| 108 | Hyperalaninemia (HP:0003348) | 2.15059682 |
| 109 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.15059682 |
| 110 | Pointed chin (HP:0000307) | 2.14792606 |
| 111 | Glucose intolerance (HP:0000833) | 2.13997102 |
| 112 | Premature graying of hair (HP:0002216) | 2.13527870 |
| 113 | Increased cerebral lipofuscin (HP:0011813) | 2.12058084 |
| 114 | High anterior hairline (HP:0009890) | 2.11791351 |
| 115 | Nuclear cataract (HP:0100018) | 2.11316283 |
| 116 | Annular pancreas (HP:0001734) | 2.11067193 |
| 117 | Tongue fasciculations (HP:0001308) | 2.10701073 |
| 118 | Atrioventricular block (HP:0001678) | 2.10666530 |
| 119 | Hepatic necrosis (HP:0002605) | 2.10434418 |
| 120 | Cervical subluxation (HP:0003308) | 2.09855483 |
| 121 | Unsteady gait (HP:0002317) | 2.09699866 |
| 122 | Tetraplegia (HP:0002445) | 2.07131443 |
| 123 | Trismus (HP:0000211) | 2.06406411 |
| 124 | Broad distal phalanx of finger (HP:0009836) | 2.05093591 |
| 125 | Absent epiphyses (HP:0010577) | 2.04323244 |
| 126 | Aplasia/Hypoplasia of the capital femoral epiphysis (HP:0005003) | 2.04323244 |
| 127 | Testicular atrophy (HP:0000029) | 2.04001580 |
| 128 | Easy fatigability (HP:0003388) | 2.01932016 |
| 129 | Metaphyseal cupping (HP:0003021) | 2.01492253 |
| 130 | Hypercholesterolemia (HP:0003124) | 2.00510039 |
| 131 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.00074569 |
| 132 | Abnormal autonomic nervous system physiology (HP:0012332) | 1.98674383 |
| 133 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.98372583 |
| 134 | Protrusio acetabuli (HP:0003179) | 1.98297388 |
| 135 | Hepatocellular necrosis (HP:0001404) | 1.98079830 |
| 136 | Diaphragmatic weakness (HP:0009113) | 1.97958095 |
| 137 | Abnormal pancreas size (HP:0012094) | 1.97834668 |
| 138 | Flattened epiphyses (HP:0003071) | 1.96587410 |
| 139 | Concave nail (HP:0001598) | 1.96501991 |
| 140 | Progressive external ophthalmoplegia (HP:0000590) | 1.96036264 |
| 141 | Abnormal spermatogenesis (HP:0008669) | 1.95637661 |
| 142 | Disproportionate tall stature (HP:0001519) | 1.95486629 |
| 143 | Hypertriglyceridemia (HP:0002155) | 1.95302928 |
| 144 | Muscle fibrillation (HP:0010546) | 1.95250435 |
| 145 | Increased serum lactate (HP:0002151) | 1.95159706 |
| 146 | Flat acetabular roof (HP:0003180) | 1.94977117 |
| 147 | Lower limb amyotrophy (HP:0007210) | 1.93612217 |
| 148 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 1.93478209 |
| 149 | Bone marrow hypocellularity (HP:0005528) | 1.92279521 |
| 150 | Axonal loss (HP:0003447) | 1.91916657 |
| 151 | Glomerulonephritis (HP:0000099) | 1.91559253 |
| 152 | Colitis (HP:0002583) | 1.91549595 |
| 153 | Spinal cord lesions (HP:0100561) | 1.91219721 |
| 154 | Syringomyelia (HP:0003396) | 1.91219721 |
| 155 | Ulnar bowing (HP:0003031) | 1.91049527 |
| 156 | Posterior subcapsular cataract (HP:0007787) | 1.90597201 |
| 157 | Selective tooth agenesis (HP:0001592) | 1.89643713 |
| 158 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 1.88179315 |
| 159 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 1.87456735 |
| 160 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.87312463 |
| 161 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.87312463 |
| 162 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.87312463 |
| 163 | Cleft eyelid (HP:0000625) | 1.86711334 |
| 164 | Cerebral inclusion bodies (HP:0100314) | 1.85967126 |
| 165 | Visual hallucinations (HP:0002367) | 1.85696119 |
| 166 | Aplasia/hypoplasia of the uterus (HP:0008684) | 1.85229934 |
| 167 | Chronic obstructive pulmonary disease (HP:0006510) | 1.85127804 |
| 168 | Obstructive lung disease (HP:0006536) | 1.85127804 |
| 169 | Insomnia (HP:0100785) | 1.83764419 |
| 170 | Absent hand (HP:0004050) | 1.83423878 |
| 171 | Nausea (HP:0002018) | 1.83343727 |
| 172 | Abnormality of macrophages (HP:0004311) | 1.83080113 |
| 173 | Abnormality of the motor neurons (HP:0002450) | 1.82284986 |
| 174 | Abnormal neuron morphology (HP:0012757) | 1.82284986 |
| 175 | Spastic paraparesis (HP:0002313) | 1.81776164 |
| 176 | Abnormality of glycolipid metabolism (HP:0010969) | 1.81100053 |
| 177 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.81100053 |
| 178 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.81100053 |
| 179 | Retinal atrophy (HP:0001105) | 1.80827187 |
| 180 | Supernumerary nipples (HP:0002558) | 1.80115880 |
| 181 | Mucopolysacchariduria (HP:0008155) | 1.79417022 |
| 182 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.79417022 |
| 183 | Bronchomalacia (HP:0002780) | 1.79061249 |
| 184 | Premature rupture of membranes (HP:0001788) | 1.78841253 |
| 185 | Polygenic inheritance (HP:0010982) | 1.78336381 |
| 186 | Vitreoretinal degeneration (HP:0000655) | 1.77749796 |
| 187 | Aplasia/Hypoplasia of the breasts (HP:0010311) | 1.77522936 |
| 188 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.77338945 |
| 189 | Abnormality of complement system (HP:0005339) | 1.75902060 |
| 190 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.73796800 |
| 191 | Complement deficiency (HP:0004431) | 1.71965204 |
| 192 | Joint hemorrhage (HP:0005261) | 1.70638393 |
| 193 | Atelectasis (HP:0100750) | 1.66951277 |
| 194 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.66495077 |
| 195 | Increased IgE level (HP:0003212) | 1.64599766 |
| 196 | Gastrointestinal inflammation (HP:0004386) | 1.64558167 |
| 197 | Upper motor neuron abnormality (HP:0002127) | 1.64253662 |
| 198 | Skin nodule (HP:0200036) | 1.64077115 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BUB1 | 6.39604874 |
| 2 | WEE1 | 4.27220132 |
| 3 | STK16 | 3.88692537 |
| 4 | TRIB3 | 3.85692512 |
| 5 | TSSK6 | 3.78490761 |
| 6 | ERN1 | 3.72875794 |
| 7 | EIF2AK1 | 3.69485564 |
| 8 | AKT3 | 2.84279529 |
| 9 | SMG1 | 2.71023528 |
| 10 | FGFR4 | 2.68465185 |
| 11 | RIPK1 | 2.59914455 |
| 12 | EPHA2 | 2.57583766 |
| 13 | SIK1 | 2.42416617 |
| 14 | ICK | 2.31923585 |
| 15 | SRPK1 | 2.18978187 |
| 16 | EIF2AK3 | 2.16275750 |
| 17 | MAP2K3 | 2.05996887 |
| 18 | TESK2 | 2.02819902 |
| 19 | BRSK1 | 2.01914422 |
| 20 | TTK | 2.01789873 |
| 21 | BRSK2 | 1.98958518 |
| 22 | NEK1 | 1.98705975 |
| 23 | PLK4 | 1.96991602 |
| 24 | SIK2 | 1.94684906 |
| 25 | BRAF | 1.85233411 |
| 26 | ZAK | 1.82920522 |
| 27 | NEK2 | 1.81579880 |
| 28 | MAP4K1 | 1.81215841 |
| 29 | PKN2 | 1.80910429 |
| 30 | NME2 | 1.78230030 |
| 31 | PLK1 | 1.76049732 |
| 32 | TLK1 | 1.75649734 |
| 33 | ACVR1B | 1.69867902 |
| 34 | PLK3 | 1.68218757 |
| 35 | ARAF | 1.67980593 |
| 36 | DYRK3 | 1.65417764 |
| 37 | CDK12 | 1.62338668 |
| 38 | NME1 | 1.59470861 |
| 39 | IRAK3 | 1.53231156 |
| 40 | PRKD3 | 1.52380060 |
| 41 | PNCK | 1.49651046 |
| 42 | PRKD2 | 1.49607684 |
| 43 | MKNK1 | 1.38990303 |
| 44 | EEF2K | 1.37991081 |
| 45 | MARK2 | 1.34674971 |
| 46 | AURKA | 1.33074699 |
| 47 | EPHB1 | 1.32033857 |
| 48 | PIM2 | 1.30761653 |
| 49 | TNK2 | 1.29604865 |
| 50 | MARK3 | 1.28356911 |
| 51 | TYRO3 | 1.27551152 |
| 52 | CCNB1 | 1.20958793 |
| 53 | TAOK2 | 1.18654383 |
| 54 | TAOK3 | 1.17509465 |
| 55 | DDR2 | 1.09550265 |
| 56 | TYK2 | 1.08421049 |
| 57 | CDC42BPA | 1.08167617 |
| 58 | MARK1 | 1.06599752 |
| 59 | PDGFRA | 1.06530346 |
| 60 | CHEK2 | 1.04359236 |
| 61 | IRAK2 | 1.02352448 |
| 62 | TBK1 | 1.01977226 |
| 63 | MKNK2 | 1.00711304 |
| 64 | VRK1 | 1.00327151 |
| 65 | RIPK4 | 0.99057090 |
| 66 | SIK3 | 0.98779025 |
| 67 | PTK2 | 0.98015088 |
| 68 | AURKB | 0.97137111 |
| 69 | RPS6KA2 | 0.97060638 |
| 70 | LATS2 | 0.96991225 |
| 71 | PTK6 | 0.96717575 |
| 72 | PDK4 | 0.93847577 |
| 73 | PDK3 | 0.93847577 |
| 74 | MAP3K10 | 0.93276784 |
| 75 | PRKCI | 0.92944121 |
| 76 | DYRK2 | 0.92805761 |
| 77 | PAK1 | 0.88977817 |
| 78 | PDPK1 | 0.87460659 |
| 79 | DYRK1B | 0.86919408 |
| 80 | MAP3K3 | 0.82676069 |
| 81 | GRK6 | 0.82656316 |
| 82 | LIMK1 | 0.80508070 |
| 83 | ALK | 0.80059241 |
| 84 | FGR | 0.79941179 |
| 85 | MAP3K13 | 0.79446108 |
| 86 | CDK19 | 0.75813535 |
| 87 | MAP3K8 | 0.74946536 |
| 88 | CDC7 | 0.74793693 |
| 89 | EPHA4 | 0.73313306 |
| 90 | ATR | 0.73298672 |
| 91 | MAP3K1 | 0.73179692 |
| 92 | RPS6KL1 | 0.73103576 |
| 93 | RPS6KC1 | 0.73103576 |
| 94 | MAP2K2 | 0.72595659 |
| 95 | HIPK2 | 0.70891099 |
| 96 | MAP3K7 | 0.70441046 |
| 97 | TESK1 | 0.69963042 |
| 98 | NTRK1 | 0.68764920 |
| 99 | LMTK2 | 0.66524310 |
| 100 | MTOR | 0.66385393 |
| 101 | CAMKK1 | 0.63680660 |
| 102 | PAK6 | 0.63357532 |
| 103 | STK38L | 0.62586723 |
| 104 | FES | 0.62168063 |
| 105 | PASK | 0.61756957 |
| 106 | DAPK1 | 0.61716539 |
| 107 | FGFR3 | 0.60817128 |
| 108 | PDK1 | 0.60175314 |
| 109 | BMX | 0.59400121 |
| 110 | MAP2K4 | 0.58787488 |
| 111 | MAPK12 | 0.56501137 |
| 112 | CHEK1 | 0.54887670 |
| 113 | MAP3K9 | 0.53768012 |
| 114 | BLK | 0.53259332 |
| 115 | CDK2 | 0.53016543 |
| 116 | CDK7 | 0.52048757 |
| 117 | PAK4 | 0.51336977 |
| 118 | CDK11A | 0.50683208 |
| 119 | RAF1 | 0.50581729 |
| 120 | BCKDK | 0.50270724 |
| 121 | UHMK1 | 0.49065653 |
| 122 | PRKCG | 0.48735018 |
| 123 | LRRK2 | 0.47802884 |
| 124 | TTN | 0.47728519 |
| 125 | RPS6KA6 | 0.47725882 |
| 126 | EPHB2 | 0.47468902 |
| 127 | ABL2 | 0.46925945 |
| 128 | PDK2 | 0.45265199 |
| 129 | CSNK2A1 | 0.45112768 |
| 130 | MAP3K11 | 0.44924129 |
| 131 | CDK15 | 0.44813972 |
| 132 | SGK3 | 0.44599663 |
| 133 | MAPK11 | 0.43997024 |
| 134 | TAOK1 | 0.43808022 |
| 135 | RET | 0.43666407 |
| 136 | CSK | 0.43248123 |
| 137 | RPS6KB2 | 0.42461264 |
| 138 | RPS6KA4 | 0.42320183 |
| 139 | KSR1 | 0.41690934 |
| 140 | ZAP70 | 0.40977627 |
| 141 | MATK | 0.40798845 |
| 142 | CSNK1E | 0.40609675 |
| 143 | CDK9 | 0.40381493 |
| 144 | EIF2AK2 | 0.39447711 |
| 145 | ILK | 0.39330610 |
| 146 | PRKD1 | 0.38881286 |
| 147 | CDK18 | 0.38735779 |
| 148 | EPHA3 | 0.38121428 |
| 149 | MAP3K6 | 0.37991467 |
| 150 | CSNK2A2 | 0.37343532 |
| 151 | PINK1 | 0.36651979 |
| 152 | CDK1 | 0.36149338 |
| 153 | CDK4 | 0.35967890 |
| 154 | CSNK1G3 | 0.31519250 |
| 155 | RPS6KA5 | 0.31058582 |
| 156 | ERBB2 | 0.29838822 |
| 157 | KDR | 0.29469708 |
| 158 | KSR2 | 0.29138978 |
| 159 | MAP3K5 | 0.28125859 |
| 160 | IRAK1 | 0.26348230 |
| 161 | CAMK2G | 0.26184017 |
| 162 | MINK1 | 0.24811771 |
| 163 | MAP2K1 | 0.23965745 |
| 164 | DAPK3 | 0.23776078 |
| 165 | PRPF4B | 0.23717917 |
| 166 | CSNK1A1 | 0.22565885 |
| 167 | IRAK4 | 0.19355415 |
| 168 | MAP2K6 | 0.18974452 |
| 169 | CAMKK2 | 0.18736861 |
| 170 | MAPK9 | 0.16387515 |
| 171 | ERBB3 | 0.14461582 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Proteasome_Homo sapiens_hsa03050 | 5.33586905 |
| 2 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 5.07559655 |
| 3 | RNA polymerase_Homo sapiens_hsa03020 | 4.57207942 |
| 4 | Other glycan degradation_Homo sapiens_hsa00511 | 3.92385374 |
| 5 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 3.82218166 |
| 6 | DNA replication_Homo sapiens_hsa03030 | 3.16932607 |
| 7 | RNA transport_Homo sapiens_hsa03013 | 3.05006223 |
| 8 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 2.83374602 |
| 9 | Spliceosome_Homo sapiens_hsa03040 | 2.66528992 |
| 10 | Ribosome_Homo sapiens_hsa03010 | 2.60518012 |
| 11 | Mismatch repair_Homo sapiens_hsa03430 | 2.53963790 |
| 12 | * Regulation of autophagy_Homo sapiens_hsa04140 | 2.43406370 |
| 13 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.34687171 |
| 14 | Notch signaling pathway_Homo sapiens_hsa04330 | 2.27696191 |
| 15 | Folate biosynthesis_Homo sapiens_hsa00790 | 2.21478763 |
| 16 | Cell cycle_Homo sapiens_hsa04110 | 2.21083119 |
| 17 | Nucleotide excision repair_Homo sapiens_hsa03420 | 2.16412554 |
| 18 | Homologous recombination_Homo sapiens_hsa03440 | 2.13078742 |
| 19 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 2.11253512 |
| 20 | Base excision repair_Homo sapiens_hsa03410 | 2.09817846 |
| 21 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.05001332 |
| 22 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 1.99584363 |
| 23 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.91508773 |
| 24 | Basal transcription factors_Homo sapiens_hsa03022 | 1.87559169 |
| 25 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.83630354 |
| 26 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.75706118 |
| 27 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.75402791 |
| 28 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.61856343 |
| 29 | Purine metabolism_Homo sapiens_hsa00230 | 1.60880021 |
| 30 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.59460969 |
| 31 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.58580440 |
| 32 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.54988579 |
| 33 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.53842172 |
| 34 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.50204609 |
| 35 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.45684426 |
| 36 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 1.41648089 |
| 37 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.41026473 |
| 38 | Prion diseases_Homo sapiens_hsa05020 | 1.39666004 |
| 39 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.38512956 |
| 40 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 1.36823762 |
| 41 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.34200422 |
| 42 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.33751281 |
| 43 | Sulfur relay system_Homo sapiens_hsa04122 | 1.32932428 |
| 44 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.32030280 |
| 45 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.30715086 |
| 46 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.27347748 |
| 47 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.24530730 |
| 48 | Oocyte meiosis_Homo sapiens_hsa04114 | 1.24373122 |
| 49 | Bladder cancer_Homo sapiens_hsa05219 | 1.24128279 |
| 50 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.23812261 |
| 51 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.19941300 |
| 52 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.19545994 |
| 53 | Leishmaniasis_Homo sapiens_hsa05140 | 1.18458612 |
| 54 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 1.16119634 |
| 55 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 1.15825486 |
| 56 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.14902200 |
| 57 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.14330409 |
| 58 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.13270943 |
| 59 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.08453380 |
| 60 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 1.05660823 |
| 61 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.05387363 |
| 62 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.05194801 |
| 63 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.03932094 |
| 64 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.00745342 |
| 65 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.99864892 |
| 66 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.99675659 |
| 67 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.96750957 |
| 68 | Hepatitis C_Homo sapiens_hsa05160 | 0.95704449 |
| 69 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.95349578 |
| 70 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.94765963 |
| 71 | Glioma_Homo sapiens_hsa05214 | 0.94129519 |
| 72 | RNA degradation_Homo sapiens_hsa03018 | 0.94008211 |
| 73 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.92958455 |
| 74 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.92846261 |
| 75 | Pertussis_Homo sapiens_hsa05133 | 0.91577591 |
| 76 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.90792430 |
| 77 | Endometrial cancer_Homo sapiens_hsa05213 | 0.88557536 |
| 78 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.86656607 |
| 79 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.84557656 |
| 80 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.83351675 |
| 81 | Carbon metabolism_Homo sapiens_hsa01200 | 0.83067038 |
| 82 | Salmonella infection_Homo sapiens_hsa05132 | 0.82843597 |
| 83 | Tuberculosis_Homo sapiens_hsa05152 | 0.82525811 |
| 84 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.82206202 |
| 85 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.82086650 |
| 86 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.81182217 |
| 87 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.79943223 |
| 88 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.78499937 |
| 89 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.76966878 |
| 90 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.75820232 |
| 91 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.74343163 |
| 92 | Protein export_Homo sapiens_hsa03060 | 0.73940683 |
| 93 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.73143553 |
| 94 | Hepatitis B_Homo sapiens_hsa05161 | 0.72359017 |
| 95 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.71957115 |
| 96 | Thyroid cancer_Homo sapiens_hsa05216 | 0.71116799 |
| 97 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.68045540 |
| 98 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.67622397 |
| 99 | Long-term potentiation_Homo sapiens_hsa04720 | 0.65843696 |
| 100 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.65301325 |
| 101 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.65049251 |
| 102 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.64537355 |
| 103 | Influenza A_Homo sapiens_hsa05164 | 0.63934857 |
| 104 | Huntingtons disease_Homo sapiens_hsa05016 | 0.62305388 |
| 105 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.62027842 |
| 106 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.59655777 |
| 107 | Lysosome_Homo sapiens_hsa04142 | 0.59542948 |
| 108 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.59053524 |
| 109 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.58670995 |
| 110 | Colorectal cancer_Homo sapiens_hsa05210 | 0.58248434 |
| 111 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.57851025 |
| 112 | Metabolic pathways_Homo sapiens_hsa01100 | 0.57361594 |
| 113 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.57223754 |
| 114 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.57170291 |
| 115 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.56861865 |
| 116 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.56536198 |
| 117 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.50316441 |
| 118 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.50125033 |
| 119 | Parkinsons disease_Homo sapiens_hsa05012 | 0.49455661 |
| 120 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.49351036 |
| 121 | Insulin resistance_Homo sapiens_hsa04931 | 0.49019245 |
| 122 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.48909413 |
| 123 | Circadian rhythm_Homo sapiens_hsa04710 | 0.47861393 |
| 124 | Phagosome_Homo sapiens_hsa04145 | 0.47147354 |
| 125 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.46454537 |
| 126 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.44645135 |
| 127 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.44518631 |
| 128 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.44392434 |
| 129 | Amoebiasis_Homo sapiens_hsa05146 | 0.43188759 |
| 130 | Galactose metabolism_Homo sapiens_hsa00052 | 0.42041092 |
| 131 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.39848908 |
| 132 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.39306614 |
| 133 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.36148784 |
| 134 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.36021501 |
| 135 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.33788739 |
| 136 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.32306534 |
| 137 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.32078696 |
| 138 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.31998320 |
| 139 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.28155283 |
| 140 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.26693180 |
| 141 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.25558162 |
| 142 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.24703914 |
| 143 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.23866879 |
| 144 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.20226723 |
| 145 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.20039034 |
| 146 | Endocytosis_Homo sapiens_hsa04144 | 0.19423887 |
| 147 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.19219334 |
| 148 | HTLV-I infection_Homo sapiens_hsa05166 | 0.19061018 |
| 149 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.17648801 |
| 150 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.16902970 |
| 151 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.16133252 |
| 152 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.14846984 |
| 153 | Apoptosis_Homo sapiens_hsa04210 | 0.14323283 |
| 154 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.13102784 |
| 155 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.12974377 |
| 156 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.12618798 |
| 157 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.12428128 |
| 158 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.12054906 |
| 159 | Legionellosis_Homo sapiens_hsa05134 | 0.11122523 |
| 160 | Shigellosis_Homo sapiens_hsa05131 | 0.08080733 |
| 161 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.07422433 |
| 162 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.06977662 |
| 163 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.06335713 |
| 164 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.05779295 |
| 165 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.05312723 |
| 166 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.05014466 |
| 167 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.03905711 |
| 168 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.03631680 |
| 169 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.03232944 |
| 170 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.03226903 |
| 171 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.03129980 |
| 172 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.01825012 |
| 173 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.00709204 |

